Live
- Sri Jagdamba Pearls Expands Presence with the launch of its Second Store in Bengaluru at Lulu Mall
- Congress remembers Dalits only in bad times: Mayawati taunts Rahul Gandhi on Parbhani visit
- Have time for jailed leaders but none for achievers: BJP slams Delhi govt over chess champion’s pain
- Alliance University holds 13th Convocation, 1145 students receive degrees
- SC orders strict action against illegal construction
- Man kills sibling over property dispute
- Karnataka gets third govt cardiology hospital
- Minister Ramalinga’s efforts help safeguard over 10,000 acres of temple Land
- Laxminarayan College gets NAAC B+ accreditation
- Champions Trophy: India vs Pakistan Match Likely to Be Held on This Date
Dr Reddy's launches generic hypotensive injection in US
Drug firm Dr Reddy's Laboratories on Monday said it has launched in the US Sodium Nitroprusside injection used for immediate reduction of blood pressure in hypertensive crises.
Hyderabad: Drug firm Dr Reddy's Laboratories on Monday said it has launched in the US Sodium Nitroprusside injection used for immediate reduction of blood pressure in hypertensive crises.
The company has launched generic Sodium Nitroprusside injection, 50 mg/2 ml (25 mg/ml) single-dose vial after getting approval from the United States Food and Drug Administration (USFDA), Dr Reddy's Labs said in a filing to the BSE.
The product is a generic version of Hospira Inc's Nitropress injection, 50 mg/2ml, it added. As per IQVIA Health data, Nitropress brand and generics had US sales of around $8 million MAT for the twelve months to October 2019, Dr Reddy's said.
Sodium Nitroprusside is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises.
